ColoRectal Cancer Clinical Trial
Official title:
Feasibility, Multi-center Prospective Study of Check-Cap's P1 Capsule System in Patients Eligible for ColoRectal Cancer [CRC] Screening
Prospective, Single arm, Multi-Center
1. To establish the safety and preliminary efficacy of the Check-Cap System in patients
with negative FOBT (Fecal Occult Blood Test)
2. To collect data about the overall imaging of the colon internal surface during the
passage of the capsule
3. To develop a correlation map between the imaging of the polyps by optical colonoscopy
vs. the images of same polyps by the Check-Cap capsule vs. the imaging of same polyps by
CT Colonography [CTC] (in patients which were referred after positive CTC examination)
Study Title:
Outside USA [OUS] Pilot Multi-center prospective feasibility study
Objectives:
Primary:
To establish the safety and preliminary efficacy of the Check-Cap System in patients with
negative FOBT (Fecal Occult Blood Test) or FIT
Secondary:
- To evaluate the safety of the device in terms of total and segmental transit time and to
study the effect of the presence of polyps and variable colon dimensions on these
parameters.
- To monitor the functionality of the activation mechanism and of the scanning circuitry
(transmitter detectors).
- To collect data about the overall imaging of the colon internal surface during the
passage of the capsule
- To develop a correlation map between the imaging of the polyps by optical colonoscopy
vs. the images of same polyps by the Check-Cap capsule vs. the imaging of same polyps by
CT Colonography (in patients which were referred after positive CTC examination)
- To estimate the total radiation exposure to each patient.
- To measure the distribution of the contrast material within the colon.
Design:
Prospective, Single arm, Multi-Center
Patient population:
Group A - First in Man:
Male and female subjects older than 40 and younger than 75 years old that are eligible for
CRC screening and meet the eligibility criteria for study enrollment.
The study population will be enriched with up to 45 patients with known polyps detected by
CTC or colonoscopy, in addition to 15 patient of the device's normal cohort.
All patients that are eligible for enrollment in the study will be tested by FOBT (Fecal
Occult Blood Test) After the Capsule test, they will be referred for optical colonoscopy as
part of the study
Group B - CE Pilot:
Male and female subjects older than 45 and younger than 75 years old that are eligible for
CRC screening and meet the eligibility criteria for study enrollment.
All patients that are eligible for enrollment in the study will be tested by FIT ,. After the
Capsule test they will be referred for optical colonoscopy Consenting patients with negative
FIT testing scheduled for clinically-indicated optical colonoscopy without contraindication
to either Check-Cap System imaging or optical colonoscopy, and able to undergo the bowel
preparation necessary for optical colonoscopy.
Sample Size:
Total of 100 patients in both groups: A:3-5 + B: 55-57 subjects.
Study Procedure:
1. st visit - recruitment and screening meeting with the Principal Investigator [PI].
Subject will receive the FIT test kit with detailed instructions for executing the test.
2. nd visit - The FIT kits will be analyzed in order to diagnose the presence of blood in
the stool.
If the bowel log form is complete and the bowel frequency is not less than once per 2
days the subject will be asked to sign the Informed Consent Form [ICF] for ingesting the
capsule.
3. rd visit - Subject will ingest the capsule and continue ingestion of contrast material.
4. th visit - Subjects will return to the PI with the excreted capsule which is expected
within 24-100 hours after ingestion.
5. th visit - All patients will undergo standard bowel preparation and optical colonoscopy
between 10 and 30 days following imaging with the Check-Cap System.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |